Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Chiang CH, Song J, Chang YC, Osataphan S, Lee YC, Chang KY, et al
Circ Res (2014) 114(6):100421
Phase 2 trial data published in 2023 showed participants receiving the highest retatrutide dose lost an average of approximately 24 percent of body weight over 48 weeks, which exceeded results seen with dual-agonist medications in comparable timeframes
Many patients wonder exactly when they will start to feel the effects and see measurable results on the scale or in their blood glucose readings
At VeCura ReSculpt , weight loss is not about shortcuts its about understanding the body, respecting its biology, and using proven medical innovation to achieve lasting change
US$ 22.02
US$ 24.71
US$ 28.67
